HI
XYL icon

Humankind Investments’s Xylem XYL Stock Holding History

Humankind Investments’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,804
Closed -$1.01M – 168
2024
Q1 		$1.01M Sell
7,804
-1,014
-11% -$123K 0.27% 48
2023
Q4 		$1.01M Sell
8,818
-264
-3% -$26.3K 0.3% 45
2023
Q3 		$827K Buy
9,082
+415
+5% +$42.8K 0.34% 42
2023
Q2 		$976K Buy
8,667
+284
+3% +$30K 0.38% 38
2023
Q1 		$878K Buy
8,383
+411
+5% +$42.9K 0.36% 42
2022
Q4 		$881K Sell
7,972
-1,039
-12% -$109K 0.38% 43
2022
Q3 		$787K Sell
9,011
-168
-2% -$15.3K 0.38% 39
2022
Q2 		$718K Sell
9,179
-4,628
-34% -$382K 0.34% 45
2022
Q1 		$1.18M Buy
13,807
+4,523
+49% +$433K 0.48% 28
2021
Q4 		$1.11M Buy
9,284
+1,062
+13% +$132K 1.4% 19
2021
Q3 		$1.02M Buy
8,222
+2,319
+39% +$298K 1.55% 16
2021
Q2 		$708K Buy
5,903
+1,951
+49% +$223K 1.26% 28
2021
Q1 		$416K Buy
+3,952
New +$401K 1.28% 29

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Humankind Investments's XYL Position: Q2 2024 in Review

Humankind Investments sold out of Xylem (XYL) in Q2 2024, closing a stake of 7,804 shares — an estimated $1.01M sold.

Humankind Investments first reported a position in XYL in Q1 2021 and held it in 13 quarters. The position peaked at $1.18M in Q1 2022. 1,033 funds tracked by Wall St. Rank hold XYL as of Q2 2024.

  • Humankind Investments reported no remaining Xylem position as of Q2 2024 after selling out during the quarter.
  • Humankind Investments sold 7,804 Xylem shares in Q2 2024, an estimated $1.01M.
  • Humankind Investments first reported a position in Xylem in Q1 2021 and held it in 13 quarters.
  • Humankind Investments's Xylem position peaked at $1.18M in Q1 2022.
  • 1,033 funds tracked by Wall St. Rank held Xylem as of Q2 2024.

Based on Humankind Investments's 13F filing for Q2 2024, filed 12 Aug 2024.